Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Altor BioScience patents

Patents where

Current Assignee

Name

Altor BioScience

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9428573 Multimeric IL-15 soluble fusion molecules and methods of making and using same	Patent 9428573 was granted and assigned to Altor BioScience on August, 2016 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	9428573	August 30, 2016
‌ US Patent 10358478 Multimeric IL-15 soluble fusion molecules and methods of making and using same	Patent 10358478 was granted and assigned to Altor BioScience on July, 2019 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	10358478	July 23, 2019
‌ US Patent 7141656 MHC complexes and uses thereof	Patent 7141656 was granted and assigned to Altor BioScience on November, 2006 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	7141656	November 28, 2006
‌ US Patent 7074905 Soluble MHC complexes and methods of use thereof	Patent 7074905 was granted and assigned to Altor BioScience on July, 2006 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	7074905	July 11, 2006
‌ US Patent 7074904 MHC complexes and uses thereof	Patent 7074904 was granted and assigned to Altor BioScience on July, 2006 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	7074904	July 11, 2006
‌ US Patent 10150805 Multimeric IL-15 soluble fusion molecules and methods of making and using same	Patent 10150805 was granted and assigned to Altor BioScience on December, 2018 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	10150805	December 11, 2018
‌ US Patent 10450359 IL-15 variants and uses thereof	Patent 10450359 was granted and assigned to Altor BioScience on October, 2019 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	10450359	October 22, 2019
‌ US Patent 9464127 Fusion molecules and IL-15 variants	Patent 9464127 was granted and assigned to Altor BioScience on October, 2016 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	9464127	October 11, 2016
‌ US Patent 9328159 Multimeric IL-15 soluble fusion molecules and methods of using same	Patent 9328159 was granted and assigned to Altor BioScience on May, 2016 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	9328159	May 3, 2016
‌ US Patent 11046747 Multimeric IL-15 soluble fusion molecules and methods of making and using same	Patent 11046747 was granted and assigned to Altor BioScience on June, 2021 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	11046747	June 29, 2021
‌ US Patent 10899821 Method of treating neoplasia with a multimeric IL-15 soluble fusion molecule	Patent 10899821 was granted and assigned to Altor BioScience on January, 2021 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	10899821	January 26, 2021
‌ US Patent 8163879 Fusion molecules and IL-15 variants	Patent 8163879 was granted and assigned to Altor BioScience on April, 2012 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	8163879	April 24, 2012
‌ US Patent 8940289 Fusion molecules and IL-15 variants	Patent 8940289 was granted and assigned to Altor BioScience on January, 2015 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	8940289	January 27, 2015
‌ US Patent 9593152 Methods of treating disease with fusion molecules comprising IL-15 variants	Patent 9593152 was granted and assigned to Altor BioScience on March, 2017 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	9593152	March 14, 2017
‌ US Patent 8492118 Fusion molecules and IL-15 variants	Patent 8492118 was granted and assigned to Altor BioScience on July, 2013 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	8492118	July 23, 2013
‌ US Patent 10537615 IL-15-based molecules and methods of use thereof	Patent 10537615 was granted and assigned to Altor BioScience on January, 2020 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	10537615	January 21, 2020
‌ US Patent 8105830 Polyspecific binding molecules and uses thereof	Patent 8105830 was granted and assigned to Altor BioScience on January, 2012 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	8105830	January 31, 2012
‌ US Patent 9925247 IL-15-based molecules and methods of use thereof	Patent 9925247 was granted and assigned to Altor BioScience on March, 2018 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	9925247	March 27, 2018
‌ US Patent 8507222 Multimeric IL-15 soluble fusion molecules and methods of making and using same	Patent 8507222 was granted and assigned to Altor BioScience on August, 2013 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	8507222	August 13, 2013
‌ US Patent 9290560 Soluble TCR molecules and methods of use	Patent 9290560 was granted and assigned to Altor BioScience on March, 2016 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	9290560	March 22, 2016
‌ US Patent 9714279 HIV vpr-specific T-cell receptors	Patent 9714279 was granted and assigned to Altor BioScience on July, 2017 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	9714279	July 25, 2017
‌ US Patent 10844107 HIV VPR-specific T-cell receptors		Altor BioScience	Altor BioScience	United States Patent and Trademark Office	10844107	November 24, 2020
‌ US Patent 8772451 Soluble TCR molecules and methods of use	Patent 8772451 was granted and assigned to Altor BioScience on July, 2014 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	8772451	July 8, 2014
‌ US Patent 11161890 IL-15-based fusions to IL-7 and IL-21	Patent 11161890 was granted and assigned to Altor BioScience on November, 2021 by the United States Patent and Trademark Office.	Altor BioScience	Altor BioScience	United States Patent and Trademark Office	11161890	November 2, 2021
‌ US Patent 8933198 HIV VPR-specific T cell receptors	Patent 8933198 was granted and assigned to Altor BioScience on January, 2015 by the United States Patent and Trademark Office.		Altor BioScience	United States Patent and Trademark Office	8933198	January 13, 2015

Results per page:

31 results

0 selected

31 results

0 selected